Description
The rapid time-to-result and flexibility of the Octet® platform has helped accelerate almost every stage of the drug development workflow in leading and start-up biotherapeutic companies. New comprehensive tools for compliance now enable application of Octet® systems to be easily integrated in analytical development and regulated GxP labs. Multiple applications, including lot release and in-process testing for ligand binding, concentration and impurity analysis (HCP, residual protein A) are increasingly being run on Octet® systems. These systems have also become a solution platform for potency analysis of drug-target and drug-Fc receptor(s) (FcγRI, FcγRIIa, FcRIII and FcRn) interactions. For more information, please see GxP applications. Octet® systems have been developed to operate in a regulated environment, with available installation and operational qualification services, maintenance support and 21 CFR Part 11-compliant software tools.